Baxter International (BAX) Current Deferred Revenue (2021 - 2024)

Baxter International (BAX) has 4 years of Current Deferred Revenue data on file, last reported at $171.0 million in Q4 2024.

• Quarterly Current Deferred Revenue rose 1.18% year-over-year to $171.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $171.0 million (up 1.18% YoY) and the FY2024 annual result came in at $171.0 million, up 1.18% from the prior year.
• Current Deferred Revenue climbed to $171.0 million in Q4 2024 per BAX's latest filing, from $169.0 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $196.0 million in Q4 2021 and bottomed at $169.0 million in Q4 2023.
• The 4-year median for Current Deferred Revenue is $172.0 million (2022), against an average of $177.2 million.
• The widest annual swing landed in 2022, when Current Deferred Revenue retreated 11.73%; it then rose 1.18% in 2024.
• Tracing BAX's Current Deferred Revenue over 4 years: stood at $196.0 million in 2021, then fell by 11.73% to $173.0 million in 2022, then retreated by 2.31% to $169.0 million in 2023, then rose by 1.18% to $171.0 million in 2024.
• Per Business Quant, the three latest BAX Current Deferred Revenue figures stand at $171.0 million (Q4 2024), $169.0 million (Q4 2023), and $173.0 million (Q4 2022).

Peer Comparison